Literature DB >> 9058780

Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.

W C Lai1, S P Pakes, K Ren, Y S Lu, M Bennett.   

Abstract

Genetically susceptible BALB/c mice were immunized i.m. with DNA for one or two Mycoplasma pulmonis Ags (A7-1, A8-1) beginning either 1 wk before (vaccination) or 1 wk after (treatment) intranasal infection with 5 x 10(4) CFU virulent M. pulmonis organisms. Immunization of mice by this method induced both humoral and cellular immunity to M. pulmonis, largely prevented infection (vaccination), and cleared an ongoing pneumonia over time (treatment). Only one Ag gene was required. Thus, DNA immunization is a potential treatment for infections and may be useful in instances when drug therapy may not be available or effective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

Authors:  S Zucchelli; S Capone; E Fattori; A Folgori; A Di Marco; D Casimiro; A J Simon; R Laufer; N La Monica; R Cortese; A Nicosia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Genetic vaccines: strategies for optimization.

Authors:  G Gregoriadis
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

Review 3.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

Review 4.  Overview of vaccines.

Authors:  G Ada
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

5.  Extent of polymorphism and selection pressure on the Trypanosoma cruzi vaccine candidate antigen Tc24.

Authors:  Audrey Arnal; Liliana Villanueva-Lizama; Christian Teh-Poot; Claudia Herrera; Eric Dumonteil
Journal:  Evol Appl       Date:  2020-09-10       Impact factor: 5.183

6.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

Authors:  Ghalia Boubaker; Andrew Hemphill; Cristina Olivia Huber; Markus Spiliotis; Hamouda Babba; Bruno Gottstein
Journal:  PLoS Negl Trop Dis       Date:  2015-06-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.